JPMorgan Chase & Co. Raises Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

JPMorgan Chase & Co. boosted its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 210.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 147,154 shares of the technology company's stock after buying an additional 99,789 shares during the period. JPMorgan Chase & Co. owned approximately 0.73% of Simulations Plus worth $4,104,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SLP. Jones Financial Companies Lllp increased its position in shares of Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after acquiring an additional 427 shares during the period. AlphaQuest LLC grew its stake in Simulations Plus by 502.9% during the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after purchasing an additional 2,243 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of Simulations Plus in the fourth quarter worth about $86,000. Quantbot Technologies LP lifted its holdings in shares of Simulations Plus by 191.6% during the fourth quarter. Quantbot Technologies LP now owns 5,371 shares of the technology company's stock worth $150,000 after purchasing an additional 3,529 shares during the period. Finally, US Bancorp DE boosted its position in Simulations Plus by 14.3% in the fourth quarter. US Bancorp DE now owns 5,687 shares of the technology company's stock valued at $159,000 after buying an additional 713 shares during the last quarter. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Simulations Plus Stock Performance

Shares of NASDAQ SLP traded down $0.12 during mid-day trading on Wednesday, reaching $35.26. The company's stock had a trading volume of 409,772 shares, compared to its average volume of 197,781. The stock has a 50-day moving average of $28.48 and a two-hundred day moving average of $30.15. The stock has a market capitalization of $709.11 million, a P/E ratio of 88.15 and a beta of 1.13. Simulations Plus, Inc. has a 1-year low of $23.01 and a 1-year high of $51.22.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The business had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business's revenue was up 22.5% on a year-over-year basis. During the same period last year, the company posted $0.20 EPS. Analysts predict that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Analysts Set New Price Targets

SLP has been the subject of several research reports. StockNews.com cut shares of Simulations Plus from a "hold" rating to a "sell" rating in a research note on Monday, April 14th. William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th. Finally, KeyCorp boosted their price target on Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Simulations Plus presently has a consensus rating of "Moderate Buy" and a consensus target price of $50.00.

Insiders Place Their Bets

In other news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the transaction, the director now owns 3,402,584 shares of the company's stock, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 19.40% of the stock is currently owned by corporate insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.